SCHEMBL23398166

SCHEMBL23398166

CC(C)(C)NC(=O)OCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(CO)s1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 20/20 0.47
ROCK1 Q13464 2/20 0.47
MYLK4 Q86YV6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113952 0.87 ROCK2 (0.53) ROCK2ROCK1MYLK4
SCHEMBL29192409 0.83 ROCK2 (0.67) ROCK2ROCK1MYLK4
SCHEMBL2778216 0.83 ROCK2 (0.47) ROCK2ROCK1MYLK4
SCHEMBL3336241 0.82 ROCK2 (0.65) ROCK2ROCK1
SCHEMBL3336238 0.82 ROCK2 (0.65) ROCK2ROCK1
SCHEMBL9883142 0.81 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL1999523 0.81 ROCK2 (0.51) ROCK2ROCK1
Hydrochloric Acid SCHEMBL112565 0.81 ROCK2 (0.65) ROCK2ROCK1MYLK4
SCHEMBL113963 0.79 ROCK2 (0.53) ROCK2ROCK1MYLK4
SCHEMBL2775044 0.78 ROCK2 (0.56) ROCK2ROCK1MYLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3828172-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2021-06-02 EP disclosed